Drug Discovery and Development: Debiotech S.A.

• Publication date: June 2012
• Report size: 26 pages

This report is a source for data, analysis and actionable intelligence on the Debiotech S.A. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover data on product description, function, ...

This report is a source for data, analysis and actionable intelligence on the Debiotech S.A. portfolio of new product development . The report provides detailed analysis on each pipeline product with data on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover data on product description, function, technology, indication, and application. The report is also supplemented with a detailed industry player profile and data on clinical trials, wherever applicable.

Scope of the Research

- Detailed industry player profile with data on business description, key industry player facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the new product development, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional data on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with data on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, industry ing and sales strategies.
- Exploit Merger and Acquisition opportunities by identifying industry players with the most innovative pipeline.
- Develop successful market-entry strategies .
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ new product development through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Nanotechnology Industry in Switzerland

Data table of Contents
Data table of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Debiotech S.A. - Major Products and Services 5
Debiotech S.A. Pipeline Products by Equipment Type 6
Debiotech S.A. Pipeline Products by Development Stage 7
Debiotech S.A. Pipeline Products by Therapy Area 8
Debiotech S.A. Pipeline Products by Milestone Summary 9
Chronoflow 10
Product Status 10
Product Description 10
DebioSTAR 10
Product Status 10
Product Description 10
Product Milestone 11
Jewel Pump 11
Product Status 11
Product Description 11
Product Milestone 12
MIP Device 12
Product Status 12
Product Description 12
Product Patent Details 13
Renal Expres 13
Product Status 13
Product Description 13
Product Milestone 14
Product Patent Details 15
Debiotech S.A. - Top Competitors 16
Debiotech S.A. - Key Executives 17
Debiotech S.A. - Operations and Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19


List of Tables

Debiotech S.A., Major development 1
Debiotech S.A. Key Pipeline Products by Equipment Type 1
Debiotech S.A. Key Pipeline Products by Therapy Area 1
Debiotech S.A. Key Pipeline Products by Development Stage 1
Debiotech S.A. Key Pipeline Products by Trial Phase 1
Debiotech S.A., Major development 4
Debiotech S.A., Major Products and Services 5
Debiotech S.A. Number of Pipeline Products by Equipment Type 6
Debiotech S.A. Pipeline Products by Equipment Type 6
Debiotech S.A. Number of Pipeline Products by Development Stage 7
Debiotech S.A. Pipeline Products by Development Stage 7
Debiotech S.A. Number of Pipeline Products by Therapy Area 8
Debiotech S.A. Pipeline Products by Therapy Area 8
Debiotech S.A. Number of Pipeline Products By Milestone Summary 9
Debiotech S.A. Pipeline Products by Milestone Summary 9
Chronoflow - Product Status 10
Chronoflow - Product Description 10
DebioSTAR - Product Status 10
DebioSTAR - Product Description 10
DebioSTAR - Product Milestone 11
Jewel Pump - Product Status 11
Jewel Pump - Product Description 11
Jewel Pump - Product Milestone 12
MIP Device - Product Status 12
MIP Device - Product Description 12
MIP Device - Patent Details 13
Renal Expres - Product Status 13
Renal Expres - Product Description 13
Renal Expres - Product Milestone 14
Renal Expres - Patent Details 15
Debiotech S.A., Key Executives 17


List of Figures

Debiotech S.A. Pipeline Products by Equipment Type 6
Debiotech S.A. Pipeline Products by Development Stage 7
Debiotech S.A. Pipeline Products by Therapy Area 8
Debiotech S.A. Pipeline Products by Milestone Summary 9

Companies mentioned Sensile Medical AG
Ypsomed Holding AG
CODAN ARGUS AG
Microflow Engineering Sa